Adverse drug reactions in neonates: a brief analysis of the FDA adverse event reporting system
IntroductionDrug trials in neonates are scarce, and the neonates may consequently be at risk of adverse drug reactions (ADRs). Spontaneous ADR reporting is an important tool for expanding the knowledge on drug safety in neonates. This study explores the quality of current neonatal ADR reports and th...
保存先:
| 主要な著者: | , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Frontiers Media S.A.
2024-06-01
|
| シリーズ: | Frontiers in Pharmacology |
| 主題: | |
| オンライン・アクセス: | https://www.frontiersin.org/articles/10.3389/fphar.2024.1395982/full |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|
